Download FREE Report Sample
Download Free sampleUrokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Urokinase Lyophilized Powder Market contains market size and forecasts of Urokinase Lyophilized Powder in global, including the following market information:
Global Urokinase Lyophilized Powder Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Urokinase Lyophilized Powder Market Sales, 2017-2022, 2023-2028, (MIU)
Global top five Urokinase Lyophilized Powder companies in 2021 (%)
The global Urokinase Lyophilized Powder market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10000-100000IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Urokinase Lyophilized Powder include NDPHARM, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems Inc and LIVZON, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urokinase Lyophilized Powder manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urokinase Lyophilized Powder Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Urokinase Lyophilized Powder Market Segment Percentages, by Type, 2021 (%)
10000-100000IU
100000-1000000IU
Others
Global Urokinase Lyophilized Powder Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Urokinase Lyophilized Powder Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Urokinase Lyophilized Powder Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Urokinase Lyophilized Powder Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urokinase Lyophilized Powder revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Urokinase Lyophilized Powder revenues share in global market, 2021 (%)
Key companies Urokinase Lyophilized Powder sales in global market, 2017-2022 (Estimated), (MIU)
Key companies Urokinase Lyophilized Powder sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NDPHARM
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems Inc
LIVZON
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
